We have isolated a series of sublines of the hormone-dependent MCF-7 human breast cancer cell line after selection both in vivo and in vitro for growth in the presence of subphysiological concentrations of estrogens. These sublines represent a model system for study of the processes leading to hormonal autonomy. The cells form growing tumors in ovariectomized athymic nude mice in the absence of estrogen supplementation but retain some responsivity to estrogen as determined by stimulation of the rate of tumor growth in vivo and by induction of progesterone receptor. An ovarianindependent but hormone-responsive phenotype may occur early in the natural progression to hormone-independent and unresponsive growth in breast cancer. We observed no change in the affinity or decrease in the level of expression of estrogen receptors and progesterone receptors among the sublines and the parental cells. Epidermal growth factor receptors are not overexpressed in ovarian-independent cells. Thus, altered hormone receptor expression may be a late event in the acquisition of a hormone-independent and unresponsive phenotype. Sublines isolated by in vivo but not in vitro selection are more invasive than the parental cells both in vivo and across an artificial basement membrane in vitro. Thus, as yet unknown tumor-host interactions may be important in the development of an invasive phenotype. Furthermore, acquisition of the ovarian-independent and invasive phenotypes can occur independently.
The plasma estrogen concentrations in ovariectomized athymic nude mice are equivalent to those of postmenopausal women (6, 7) . Thus, human breast tumors growing in these animals could provide a potential model for studying the natural progression from ovarian dependence to hormone insensitivity. The majority of estrogen-responsive human breast cancer cell lines currently available are fully dependent on 17f3-estradiol (E2) for growth in ovariectomized nude mice.
In this study, we report the systematic isolation of sublines of the ovarian-dependent human breast cancer cell line MCF-7 by prolonged withdrawal from potent estrogenic stimuli both in vivo in the nude mouse (MIII) and in vitro (BSK-2, BSK-3). MIII and BSK cells have acquired the ability to form progressively growing tumors in ovariectomized athymic nude mice but retain some E2 responsivity in vivo.
In addition to acquiring ovarian-independent growth, the majority of breast tumors also become invasive and metastatic. The cells isolated from tumors growing in ovariectomized mice (MIII) are more invasive both in vitro in an artificial basement membrane model and in vivo than cells derived after E2 deprivation in vitro (BSK). Therefore, these cell lines provide a unique system for studying the early events associated with progression from hormone-dependent to hormone-independent growth and invasiveness in human breast cancer. A major problem in cancer biology concerns the changes in cancer cells that result in alterations in their responses to cytotoxic drugs and hormones. While many nonmetastatic breast tumors are initially estrogen dependent, the development of curative endocrine treatments has been largely impeded by the almost inevitable progression to a hormoneindependent and metastatic phenotype. The early events characterizing progression from hormone dependence to insensitivity and from nonmetastatic to metastatic growth remain unclear.
Progression from hormone-dependent to -independent growth has been widely reported in experimental rodent cancers. Some mouse mammary and rat prostatic hormonedependent tumors appear to become hormone independent and unresponsive after acquisition of an intermediate hormone-independent but hormone-responsive phenotype (1, 2) . However, the rapidity of progression to hormone-independent growth (3, 4) and the initial dependence on prolactin (5) limit the use of rodent mammary models for the study of human disease.
MATERIALS AND METHODS
Cell Culture. MCF-7 cells were originally provided by Marvin Rich (Michigan Cancer Foundation) and were routinely maintained in improved minimal essential medium (IMEM) (Biofluids, Rockville, MD) containing phenol red (PR) and supplemented with 5% fetal calf serum. BSK-2 cells were grown in IMEM containing PR and supplemented with 5% fetal calf serum stripped of endogenous steroids and steroid sulfates (charcoal-treated calf serum, CCS). BSK-3 and MIII cells were maintained in IMEM without PR and supplemented with 5% CCS. Serum was stripped of endogenous steroids by treatment with dextran-coated charcoal and type IV sulfatase (EC 3.1.6.1) (Sigma) as described (8) .
Isolation of MIII, BSK-2, and BSK-3 Cells. MIII cells were isolated from one of three small slowly proliferating MCF-7 tumors that arose in an ovariectomized National Cancer Institute BALB/c nu/nu athymic nude mouse 6 months after cell inoculation. The absence of ovaries was confirmed at the time of tumor excision. The tumor was removed and explant cultures were initiated in IMEM without PR and supplemented with 5% CCS, gentamicin sulfate (50 Ag/ml), penicillin (100 units/ml), streptomycin (100 ,ug/ml), and fungizone (0.25 tkg/ml). Subsequently (6) . Tumor area was determined twice weekly by measuring the longest axis and the width of the tumor perpendicular to the longest axis. Tumor growth curves and tumor incidence determinations were based only on data obtained from proliferating tumors.
Chunainvasion Assay. The Boyden chamber chemoinvasion assay was performed as described (13) . Polycarbonate filters (pore size, 12 ,m; polyvinylpyrrolidone free; Nuclepore) were coated with matrigel (25 ,g per filter), a mixture of basement membrane components (kindly provided by Hynda Kleinman, National Institutes of Health, Bethesda, MD). The chemoattractant was obtained by incubating confluent NIH 3T3 cells for 24 hr with IMEM. Cells (3 x 105) were added to the top chamber and incubated in a humidified incubator at 37°C for 6, 9, or 12 hr. Cells that had traversed the matrigel and attached to the lower surface of the filter were stained with Diff-Quick (American Scientific Products, Washington, DC) and quantitated electronically with an Optomax V image analyzer.
Chemotaxis Assay. Chemotaxis assays were performed in parallel to the chemoinvasion assays using the same cells and conditioned medium. This assay is similar to the chemoinvasion studies but the filter surfaces were coated with 5 ,ug of collagen IV (kindly provided by Roy Ogle, National Institutes of Health) in place of matrigel. (Fig. 1) , MIII, BSK-2, and BSK-3 cells ( Fig. 1 ; Table 2 ) form growing tumors in the absence of E2. However, E2 stimulates the proliferation of the ovarian-independent tumors, suggesting that these cells have progressed to an ovarian-independent but hormoneresponsive phenotype. For MIII cells growing in the absence of E2, the incidence of ovarian-independent tumor formation increases with time in culture, reaching the level observed in E2-supplemented mice between passages 12 and 20. We do not observe any significant MCF-7 tumor incidence in ovariectomized animals, the one exception being the experiment that gave rise to the tumors from which MIII cells were derived (Fig. 2) .
RESULTS
Hormone Receptor Expression. BSK-3 cells have retained the 2-to 3-fold increase in ER expression described (9) , but the levels in MIII and BSK-2 cells are not significantly different from parental cells ( Table 3 ). The dissociation constant for ER and ligand in all the ovarian-independent cells is equivalent to that in MCF-7 cells, being in the range of 0.1-0.5 nM. Although the MIII and BSK cell lines do not (Fig. 3) . However, MIII tumors often exhibit considerable invasion into surrounding tissues, leading to occasional intraperitoneal tumor formation. Intraperitoneal tumors occur in both the presence and absence of E2 supplementation. Fig. 3A shows an MIII tumor invading through the peritoneal wall. In contrast, MCF-7 and BSK tumors are frequently encapsulated and show no evidence of local invasion into the peritoneal cavity. Fig. 3B shows a representative MCF-7 tumor growing subcutaneously but no significant invasion into surrounding skin tissue. While BSK cells possess similar chemoinvasive properties as the parental cell line, MIII cells are significantly more invasive across an artificial basement membrane in vitro (Fig. 4) . Thus, under conditions in which 
DISCUSSION
Characterization of the Hormone-Independent but Responsive Phenotype. The E2 dependence of MCF-7 cells for tumor formation in ovariectomized mice is widely reported (6, 14, 16, 17) and may reflect, in part, the routine maintenance of these cells in the presence of estrogen. The ability of MIII and BSK cells to form E2-responsive tumors in ovariectomized animals clearly indicates that they have progressed to the intermediate stage of hormone-independent but hormoneresponsive growth observed in experimental rodent mammary and prostate cancers (1, 2).
The incidence of MIII tumors in ovariectomized animals reaches the incidence observed in E2-supplemented animals between 12 and 20 passages after establishment in vitro. Thus, further adaptation occurred after their initial development in vivo, perhaps reflecting either the progressive elimination or adaptation of some subpopulations as implied by the observed alterations in the chromosome number range. Since the BSK and MIII cell lines are not clonal in origin, the ovarian-independent but responsive phenotype could reflect the presence of at least two populations of cells, one ovarian dependent and the other independent.
Ovarian-independent and hormone-unresponsive cell lines and tumors are frequently characterized by a loss of ER and elevated EGF-R expression (18, 19) . MIII and BSK-2 cells express similar levels of ER to the parent cell line. EGF-R levels are equivalent in MCF-7 and BSK-2 cells and lower in BSK-3 and MIII cells. The different levels of expression of EGF-R may reflect the presence or absence of estrogenic stimuli, since EGF-R in human breast cancer cells is reported to be increased by treatment with E2 (20) . The PR present in BSK-2 cell culture medium could be providing the estrogenic stimulus responsible for the elevated EGF-R levels relative to MIII and BSK-2 cells (9). Acquisition of ovarian-independent and hormone-unresponsive growth in some rat mammary tumors occurs without significant loss of ER and PGR expression (21) . Thus, loss of either ER or PGR and/or overexpression of EGF-R may occur in the later stages of Cell Biology: Clarke et 238,660 ± 94,900 9620 ± 3260 60,190 ± 5,980 Cells were grown in IMEM without PR and supplemented with 5% CCS and exposed to 1 nM E2 for 48 hr prior to determining PGR induction. For each experiment, specific binding data for transformation were obtained in triplicate. Transformation was performed with the LIGAND receptor binding program (15) and the number of sites per cell was determined. Values represent the mean ± SEM of three or more experiments. Statistical comparisons were performed on EGF-R levels using Student's t test (MCF-7 versus BSK-2, P > 0.1; MCF-7 versus BSK-3, P < 0.01; MCF-7 versus MIII, P < 0.01). malignant progression, perhaps not until after the fully hormone-independent and -unresponsive phenotype is expressed. Loss of receptors also appears to be a late event in the progression of androgen-dependent tumors to independent growth (22) . However, additional pressures-e.g., endocrine manipulation (23) or cytotoxic chemotherapy (11, 24) -could influence the kinetics of altered receptor expression.
Ovarian-independent cells could be supersensitive to estrogens (25) . An increased sensitivity to estrogens could result in either elevated basal levels of PGR synthesis or an altered sensitivity to antiestrogens. However, both BSK-3 (9) and MIII cells (26) retain a sensitivity to antiestrogens equivalent to MCF-7 cells. All cell lines express approximately equivalent and low PGR levels in the absence of E2.
MIII and BSK cells could obtain sufficient estrogens to circumvent the need for E2 supplementation by metabolizing steroid precursors present in mouse serum. However, only low levels of aromatase activity are observed in human breast tumors (27) and there is no clear evidence supporting a significant role for sulfatase activity in breast cancer cells in culture (8, 28) . The majority of steroid interconversions are thought to occur primarily in peripheral tissues (8, 27, 28 PGR Induction and the Mitogenic Response to E2. Data obtained in vitro suggest that the proliferative responses to E2 are dissociated from the induction of PGR synthesis (9) . However, this may be an oversimplification since BSK-3 and MIII cells retain antiestrogen sensitivity (9, 25) and E2-induced PGR induction in vitro and E2-stimulated proliferation in vivo. Thus, induction of PGR synthesis remains a good indicator of a functional ER system. Moreover, while the in vitro growth responses would characterize MIII and BSK cells as being fully estrogen independent, they have clearly retained E2 responsivity in vivo. These observations indicate potential restrictions on the extrapolation of data obtained from in vitro studies to the in vivo context. Acquisition of the Invasive Phenotype. Invasion through the basement membrane is an important initial stage in metastasis. The ability of MIII but not BSK cells to invade locally in vivo and through basement membrane components in vitro indicate that tumor-host interactions may be important in the development of an invasive phenotype. It has been suggested that interactions between macrophages and tumor cells may be responsible for progression to a metastatic phenotype in mouse mammary tumors (29) . The differential invasive properties of MIII and BSK cells implies that acquisition of the ovarian-independent and invasive phenotypes can occur independently.
The ovarian-independent but hormone-responsive phenotype may be an early stage in the progression from dependent to independent and unresponsive growth, with loss of ER and PGR or increased expression of EGF-R occurring later in the process. Since the plasma estrogen concentrations in ovariectomized athymic nude mice are equivalent to those in postmenopausal women (6, 7), MIII and BSK xenografts provide a unique model system to study the acquisition of hormone autonomy and breast tumor growth in these women.
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